Evidence map›Paper›PMID 29444152›Full record

SynthesisPloS one2018

The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis.

Thomas Stephanus Johannes Vaessen, Lea de Jong, Annika Theresia Schäfer, Thomas Damen, Aniek Uittenboogaard, Pauline Krolinski, Chinyere Vicky Nwosu, Florentina Maria Egidius Pinckaers, Iris Leah Marije Rotee, Antonius Petrus Wilhelmus Smeets and 6 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. The Role of Cannabis in the Development of Psychosis.Turk psikiyatri dergisi = Turkish journal of psychiatry · 2024
    Review
  7. Cannabis Pharmacogenomics: A Path to Personalized Medicine.Current issues in molecular biology · 2023
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Thomas Stephanus Johannes VaessenStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Lea de JongStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Annika Theresia SchäferStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Thomas DamenStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Aniek UittenboogaardStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Pauline KrolinskiStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Chinyere Vicky NwosuStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Florentina Maria Egidius PinckaersStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Iris Leah Marije RoteeStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Antonius Petrus Wilhelmus SmeetsStudent Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-1868-3631
Ayşegül ErmişDepartment of Psychiatry, Bakirkoy Mazhar Osman Mental Health and Neurological Diseases Education and Research Hospital, Istanbul, Turkey.
James L KennedyNeurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Dorien H NiemanDepartment of Psychiatry, Academic Medical Center, Amsterdam, the Netherlands.
Arun TiwariNeurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Jim van OsDepartment of Psychiatry and Psychology, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.
Marjan DrukkerDepartment of Psychiatry and Psychology, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-6346-2662

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeither environmental nor genetic factors are sufficient to predict the transdiagnostic expression of psychosis. Therefore, analysis of gene-environment interactions may be productive.

objectiveA meta-analysis was performed using papers investigating the interaction between cannabis use and catechol-O-methyl transferase (COMT) polymorphism Val158Met (COMTVal158Met). DATA SOURCES: PubMed, Embase, PsychInfo. STUDY ELIGIBILITY CRITERIA: All observational studies assessing the interaction between COMTVal158Met and cannabis with any psychosis or psychotic symptoms measure as an outcome. STUDY APPRAISAL AND SYNTHESIS

methodsA meta-analysis was performed using the Meta-analysis of Observational Studies in Epidemiology guidelines and forest plots were generated. Thirteen articles met the selection criteria: 7 clinical studies using a case-only design, 3 clinical studies with a dichotomous outcome, and 3 studies analysing a continuous outcome of psychotic symptoms below the threshold of psychotic disorder. The three study types were analysed separately. Validity of the included studies was assessed using "A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions".

resultsFor case-only studies, a significant interaction was found between cannabis use and COMTVal158Met, with an OR of 1.45 (95% Confidence Interval = 1.05-2.00; Met/Met as the risk genotype). However, there was no evidence for interaction in either the studies including dichotomous outcomes (B = -0.51, 95% Confidence Interval -1.72, 0.70) or the studies including continuous outcomes (B = -0.04 95% Confidence Interval -0.16-0.08). LIMITATION: A substantial part of the included studies used the case-only design, which has lower validity and tends to overestimate true effects.

conclusionThe interaction term between cannabis use and COMTVal158Met was only statistically significant in the case-only studies, but not in studies using other clinical or non-clinical psychosis outcomes. Future additional high quality studies might change current perspectives, yet currently evidence for the interaction remains unconvincing.

Indexed as

CannabisPolymorphism, Single NucleotideCatechol O-MethyltransferaseHumansMethioninePsychotic DisordersValineCatechol O-MethyltransferaseMethionineValine

Identifiers

PMID29444152
PMCPMC5812637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.